Wuhan Grand Pharmaceutical Group Co., Ltd. ( China (Mainland))

Wuhan Grand Pharmaceutical Group Co., Ltd., founded in 1939 in Taihang Mountains revolutionary base, is sino-foreign joint pharmaceutical enterprise with registered capital of 85 million yuan. The company covers an area of 300 acres and has construction area of 96,000 square meters. The company is engaged in pharmaceutical preparations, pharmaceutical raw materials and intermediates with annual sales of 4 billion and annual export volume of 15 million U.S. dollars. The company has annual production capacity of 200 million of liquid formulations, over 40 100 million of solid formulations, more than 4000 tons of bulk drugs.

The company is a designated enterprise to offer National strategic reserve emergency medicine and narcotics which has more than 400 varieties of products and self-developed 12 new drugs. The company passed GMP certification, in which Norepinephrine bitartrate (69815-49-2) was certified by the U.S. FDA.